NEOG

Neogen Corp. (NEOG) | Rumor.io

Neogen

NEOG

Attention (50-day avg)0%

Attention rank (50-day avg)#1,581

Bullish sentiment (50-day avg)90%

Price to earnings ratio865

Market capitalization3B

Earnings per share-0.04

Dividend yield (TTM)—

Revenue (annual)870.4M

Net income (annual)-7.9M

Social

What share of all stock conversation is about NEOG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% 0

Apr 9

Neogen Corporation's ($NEOG) Q3 2026 revenue declined 4.4% YoY to $211.2M, with a net loss of $17M, and adjusted EPS of $0.09.
Food Safety revenue increased 2.6% YoY to $156.7M, but Animal Safety revenue declined 20.1% due to third-party supplier issues.
Neogen reaffirmed its full-year guidance of $857M-$860M revenue, despite Q3 weakness, with analysts split on the stock's prospects.

Generated by AI

Sentiment

Of the messages about NEOG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	66.67% -1.75	68.35% -31.65	89.08% +15.42
Bearish	—	33.33% +1.75	31.65% +31.65	10.92% -15.42

Jan 8

$NEOG has surged 31.84% to $9.73, breaking the $8.2777 resistance, and is expected to rise above $13.53 following its strong earnings beat and raised outlook.
The company's Q2 revenue of $224.7M has crushed estimates, with a 2.9% core growth YoY, and adjusted EPS of $0.10 beating $0.08 estimates.
Neogen's Q2 beat and raised FY26 sales have triggered a gap breakout, with a short ratio of 5.35 and 9.42% short float, indicating a potential short-squeeze risk.

Generated by AI

Topics

Of the messages about NEOG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	1.98%	1.98%	32%
Technical Analysis	—	98.02%	98.02%	13.13%
Analysts	—	0%	0%	26.07%
Controversies	—	0%	0%	0.09%
Earnings	—	0%	0%	26.8%
Macro	—	0%	0%	1.91%

Earnings· Oct 9

Neogen Corporation ($NEOG) reported Q1 2026 earnings with adjusted EPS of $0.04, in line with estimates, and revenue of $209.2M, beating expectations of $204.16M.
The company reaffirmed its FY26 revenue guidance of $820M-$840M, above consensus estimates, and announced cost-cutting measures to boost margins.
Net income was $36.3M, driven by a non-cash gain from the sale of the Cleaners & Disinfectants business, while adjusted net income declined due to lower operating income.

Announcements· Jan 8

Neogen Corporation ($NEOG) reported Q2 FY26 earnings, with adjusted EPS of $0.10, beating estimates, and revenue of $224.7M, also exceeding expectations despite a 2.8% YoY decline.
The company raised its FY26 revenue and EBITDA guidance, with a new forecast of $845M-$855M, up from its prior range of $820M-$840M, following a cost-cutting plan and companywide layoffs.
Neogen's stock surged more than 30% after the earnings release, marking the second consecutive quarter of a significant stock price increase following earnings, with the company's CEO attributing the improvement to a "pivotal stabilization point" under new leadership.

Generated by AI

Community

Of the messages about NEOG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	66.22%	35.42%	8.35%
Newcomers	—	33.78%	64.58%	91.65%

Regulars· Apr 9

Revenue for Neogen Corporation ($NEOG) beat estimates at $211.2M, but still declined year-over-year by 4.4%.
The company's adjusted EPS of $0.09 also beat estimates, but declined year-over-year by 10% from $0.10.
Neogen's food safety segment grew 2.6% year-over-year, but the animal safety segment declined sharply due to third-party supplier issues.

Newcomers· Apr 9

The newcomers are focusing on Neogen Corporation's recent financial performance, with the company reporting a net loss of $17 million and a 20.1% decline in animal safety revenue.
The newcomers are concerned about the impact of Neogen's Q3 2026 earnings on the stock price, with the stock price down 11% despite a guidance hike and earnings beat.
The newcomers are discussing the divestiture of Neogen's global genomics business to Zoetis Inc. for $160 million, and its potential effect on the company's outlook, which is expected to be $857M - $860M.

Generated by AI

News

Neogen (NEOG) Stock Trades Down, Here Is Why

12h agoYahoo Finance

Why is Neogen Stock Trading Lower on Tuesday? - Neogen (NASDAQ:NEOG)

FDA warns Neogen Vet after fungal contamination in HYCOAT solution caused unprecedented horse deaths and severe manufacturing defects.

16h agoBenzinga

Neogen drops after FDA warning over Hycoat (NEOG:NASDAQ)

20h agoSeeking Alpha

Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analy

Neogen will report Q1 earnings Oct. 6, with EPS forecast at 5 cents and revenue at $208.18M; analysts recently raised ratings and targets.

5d agoBenzinga

Neogen (NEOG) Stock Looks Fully Valued On Its Sales Base

Neogen has delivered a sharp share price swing in a short span, and the recent run has investors asking whether the current valuation is still grounded in its sales profile. With the stock now reflecting a very different market view than a few years ago, the key issue is how that view lines up with what the business actually generates in revenue. The stock has returned 153.2% over the past year, which puts real pressure on the question of whether today’s price can be explained by its sales...

5d agoYahoo Finance

Neogen Chemicals Raises ₹600 Crore via Qualified Institutions Placement

Tipranks Press Release.

12d agotheglobeandmail.com

Also Discussed

Investors talking about NEOG also mention

#	Name	Attention
1	Apogee Enterprises IncAPOG	0%0
2	ICF International, Inc.ICFI	0%new
3	AZPN - Aspen Technology, Inc.	——
4	J.B. Hunt Transport Services, Inc.JBHT	0%new
5	ALTR - Altair Engineering Inc.	——
6	Tronox Holdings plcTROX	0%new
7	Flex Ltd.FLEX	0%0
8	Diodes IncorporatedDIOD	0%new
9	IES Holdings, Inc.IESC	0%0
10	Corcept Therapeutics Inc.CORT	0%new

Neogen Corp.

Healthcare
Medical Devices

Neogen Corp. is a food and animal safety company that develops, manufactures, and markets diagnostic and testing solutions for regulated industries. Its Food Safety segment provides test kits, culture media, and related products used by food and feed producers, processors, laboratories, and regulators to detect pathogens, allergens, toxins, drug residues, and sanitation issues. Its Animal Safety segment supplies veterinary instruments, consumables, disinfectants, rodent and insect control products, pharmaceuticals, vaccines, and diagnostic products for veterinarians, livestock producers, and animal health distributors. Neogen Corp. also offers genomics-related services and other products that support animal health and food production workflows. Headquartered in Lansing, Michigan, the company serves customers across food processing, animal protein, agriculture, and companion-animal markets in the United States and internationally.

Website

Location

620 Lesher Place

Lansing, MI, 48912-1595

United States

Social

What share of all stock conversation is about NEOG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% 0

Apr 9

Neogen Corporation's ($NEOG) Q3 2026 revenue declined 4.4% YoY to $211.2M, with a net loss of $17M, and adjusted EPS of $0.09.
Food Safety revenue increased 2.6% YoY to $156.7M, but Animal Safety revenue declined 20.1% due to third-party supplier issues.
Neogen reaffirmed its full-year guidance of $857M-$860M revenue, despite Q3 weakness, with analysts split on the stock's prospects.

Generated by AI

Sentiment

Of the messages about NEOG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	66.67% -1.75	68.35% -31.65	89.08% +15.42
Bearish	—	33.33% +1.75	31.65% +31.65	10.92% -15.42

Jan 8

$NEOG has surged 31.84% to $9.73, breaking the $8.2777 resistance, and is expected to rise above $13.53 following its strong earnings beat and raised outlook.
The company's Q2 revenue of $224.7M has crushed estimates, with a 2.9% core growth YoY, and adjusted EPS of $0.10 beating $0.08 estimates.
Neogen's Q2 beat and raised FY26 sales have triggered a gap breakout, with a short ratio of 5.35 and 9.42% short float, indicating a potential short-squeeze risk.

Generated by AI

Topics

Of the messages about NEOG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	1.98%	1.98%	32%
Technical Analysis	—	98.02%	98.02%	13.13%
Analysts	—	0%	0%	26.07%
Controversies	—	0%	0%	0.09%
Earnings	—	0%	0%	26.8%
Macro	—	0%	0%	1.91%

Earnings· Oct 9

Neogen Corporation ($NEOG) reported Q1 2026 earnings with adjusted EPS of $0.04, in line with estimates, and revenue of $209.2M, beating expectations of $204.16M.
The company reaffirmed its FY26 revenue guidance of $820M-$840M, above consensus estimates, and announced cost-cutting measures to boost margins.
Net income was $36.3M, driven by a non-cash gain from the sale of the Cleaners & Disinfectants business, while adjusted net income declined due to lower operating income.

Announcements· Jan 8

Neogen Corporation ($NEOG) reported Q2 FY26 earnings, with adjusted EPS of $0.10, beating estimates, and revenue of $224.7M, also exceeding expectations despite a 2.8% YoY decline.
The company raised its FY26 revenue and EBITDA guidance, with a new forecast of $845M-$855M, up from its prior range of $820M-$840M, following a cost-cutting plan and companywide layoffs.
Neogen's stock surged more than 30% after the earnings release, marking the second consecutive quarter of a significant stock price increase following earnings, with the company's CEO attributing the improvement to a "pivotal stabilization point" under new leadership.

Generated by AI

Community

Of the messages about NEOG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	66.22%	35.42%	8.35%
Newcomers	—	33.78%	64.58%	91.65%

Regulars· Apr 9

Revenue for Neogen Corporation ($NEOG) beat estimates at $211.2M, but still declined year-over-year by 4.4%.
The company's adjusted EPS of $0.09 also beat estimates, but declined year-over-year by 10% from $0.10.
Neogen's food safety segment grew 2.6% year-over-year, but the animal safety segment declined sharply due to third-party supplier issues.

Newcomers· Apr 9

The newcomers are focusing on Neogen Corporation's recent financial performance, with the company reporting a net loss of $17 million and a 20.1% decline in animal safety revenue.
The newcomers are concerned about the impact of Neogen's Q3 2026 earnings on the stock price, with the stock price down 11% despite a guidance hike and earnings beat.
The newcomers are discussing the divestiture of Neogen's global genomics business to Zoetis Inc. for $160 million, and its potential effect on the company's outlook, which is expected to be $857M - $860M.

Generated by AI

Neogen

Social

Apr 9

Jan 8

Earnings· Oct 9

Announcements· Jan 8

Regulars· Apr 9

Newcomers· Apr 9

Neogen (NEOG) Stock Trades Down, Here Is Why

Why is Neogen Stock Trading Lower on Tuesday? - Neogen (NASDAQ:NEOG)

Neogen drops after FDA warning over Hycoat (NEOG:NASDAQ)

Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analy

Neogen (NEOG) Stock Looks Fully Valued On Its Sales Base

Neogen Chemicals Raises ₹600 Crore via Qualified Institutions Placement

Also Discussed

Neogen Corp.

Company Information

Location

Neogen (NEOG) Stock Trades Down, Here Is Why

Why is Neogen Stock Trading Lower on Tuesday? - Neogen (NASDAQ:NEOG)

Neogen drops after FDA warning over Hycoat (NEOG:NASDAQ)

Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analy

Neogen (NEOG) Stock Looks Fully Valued On Its Sales Base

Neogen Chemicals Raises ₹600 Crore via Qualified Institutions Placement

Also Discussed

Social

Apr 9

Jan 8

Earnings· Oct 9

Announcements· Jan 8

Regulars· Apr 9

Newcomers· Apr 9